KALA (KALA BIO, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by KALA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-22 | David E. Lazar | Chief Executive Officer | J | — | — |
| 2025-11-26 | David E. Lazar | Chief Executive Officer | A | — | — |
| 2025-10-24 | Romulus K Brazzell | SEE REMARKS | Sell | — | — |
| 2025-10-24 | Mark T Iwicki | Director | Sell | — | — |
| 2025-10-24 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | — | — |
| 2025-10-24 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-10-24 | Todd Bazemore | Director | Sell | — | — |
| 2025-10-02 | BAKER BROS. ADVISORS LP | — | Sell | — | — |
| 2025-09-02 | Todd Bazemore | SEE REMARKS | A | — | — |
| 2025-06-26 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | — | — |
| 2025-06-26 | Romulus K Brazzell | SEE REMARKS | Sell | — | — |
| 2025-06-26 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-06-26 | Mark T Iwicki | Director | Sell | — | — |
| 2025-06-26 | Todd Bazemore | SEE REMARKS | Sell | — | — |
| 2025-06-17 | Howard B Rosen | Director | A | — | — |
| 2025-06-17 | Mark T Iwicki | Director | A | — | — |
| 2025-06-17 | C. Daniel Myers | Director | A | — | — |
| 2025-06-17 | ANDREW I KOVEN | Director | A | — | — |
| 2025-06-17 | GREGORY D PERRY | Director | A | — | — |
| 2025-06-17 | Marjan Farid | Director | A | — | — |
| 2025-06-05 | Mark T Iwicki | Director | Sell | — | — |
| 2025-06-04 | Romulus K Brazzell | SEE REMARKS | Sell | — | — |
| 2025-06-04 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-06-04 | Todd Bazemore | SEE REMARKS | Sell | — | — |
| 2025-06-04 | Mark T Iwicki | Director | Sell | — | — |
| 2025-06-04 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | — | — |
| 2025-03-10 | Todd Bazemore | SEE REMARKS | A | — | — |
| 2025-01-10 | Romulus K Brazzell | SEE REMARKS | — | — | — |
| 2025-01-07 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2025-01-07 | Romulus K Brazzell | SEE REMARKS | MIXED | — | — |
| 2025-01-07 | Darius Kharabi | CHIEF BUSINESS OFFICER | MIXED | — | — |
| 2025-01-07 | Mary Reumuth | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-01-07 | Todd Bazemore | SEE REMARKS | MIXED | — | — |
| 2024-12-31 | JULIAN BAKER | 10%+ Owner | Buy | — | — |
| 2024-06-27 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | — | — |
| 2024-06-27 | Todd Bazemore | SEE REMARKS | Sell | — | — |
| 2024-06-27 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2024-06-27 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | Sell | — | — |
| 2024-06-27 | Romulus K Brazzell | SEE REMARKS | Sell | — | — |
| 2024-06-12 | GREGORY D PERRY | Director | A | — | — |
| 2024-06-12 | Marjan Farid | Director | A | — | — |
| 2024-06-12 | ANDREW I KOVEN | Director | A | — | — |
| 2024-06-12 | Mark S. Blumenkranz | Director | A | — | — |
| 2024-06-12 | Howard B Rosen | Director | A | — | — |
| 2024-06-12 | C. Daniel Myers | Director | A | — | — |
| 2024-06-03 | Romulus K Brazzell | SEE REMARKS | Sell | — | — |
| 2024-06-03 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | — | — |
| 2024-06-03 | Todd Bazemore | SEE REMARKS | Sell | — | — |
| 2024-06-03 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | Sell | — | — |
| 2024-06-03 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 4,370 | — |
| — | Director | 4,354 | — |
| — | Director | 3,631 | — |
| — | Director | 2,819 | — |
| — | 10%+ Owner | 2,370 | — |
| — | Director | 2,071 | — |
| — | Director | 1,817 | — |
| — | SEE REMARKS | 1,386 | — |
| — | 10%+ Owner | 1,381 | — |
| — | 10%+ Owner | 1,346 | — |
| — | Director | 1,168 | — |
| — | 10%+ Owner | 951 | — |
| — | — | 930 | — |
| — | CHIEF BUSINESS OFFICER | 835 | — |
| — | 10%+ Owner | 823 | — |
| — | SEE REMARKS | 719 | — |
| — | SEE REMARKS | 719 | — |
| — | Director | 649 | — |
| — | CHIEF FINANCIAL OFFICER | 578 | — |
| — | 10%+ Owner | 356 | — |
| — | Director | 339 | — |
| — | Director | 330 | — |
| — | Director | 267 | — |
| — | 10%+ Owner | 220 | — |
| — | 10%+ Owner | 220 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KALA quote page; the site-wide leaderboard is on the insider transactions hub.